WECHITA RECALDE: Open Payments
NPI 1366017584 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,895 in 113 payments from 18 companies in 2025. Trend: 2023 $1,249 · 2024 $1,333 · 2025 $1,895
Food & beverage: $1,785Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $454 |
| GENZYME CORPORATION | 12 | $341 |
| ABBVIE INC. | 22 | $299 |
| Regeneron Healthcare Solutions, Inc. | 9 | $171 |
| Incyte Corporation | 7 | $128 |
| PFIZER INC. | 6 | $91 |
| Amgen Inc. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| LEO Pharma Inc. | 3 | $73 |
| Galderma Laboratories, L.P. | 2 | $38 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, OPZELURA, CIBINQO, OTEZLA, COSENTYX, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
